Table of Contents
<< Previous Issue | Apr 2008 (Vol: 2008, Issue: 94) | Next Issue >> |
- Section: Business Commentaries
-
The Times They Are A-Changing
- Section: Cartoons
-
Removals
- Section: Deal Trackers
-
Bifeprunox
- Section: Features
-
Pfizer's Changing Strategy
-
Roche - Still One Step Ahead?
-
Competition Law and Intellectual Property Strategy in the Pharmaceuticals Sector: a review of a recently published report
-
Therapy Focus - Type 1 Diabetes, the Latest Developments
- Section: General
-
Effective Benchmarking
-
Merz Pharmaceutical GmbH
- Section: Licensing
-
Endo In-licenses Novartis Pain Product
-
Amgen Licenses Monoclonal Antibody from Kyowa Kakko
-
Astellas and CoMentis Enter into Deal for Novel Alzheimer's Drug
-
Dyax and Cubist Sign Deal for DX-88 Surgical Indications
- Section: Mergers & Acquisitions
-
Dr. Reddy's Acquisition Sweeps through Europe
-
EUSA Pharma to Acquire Cytogen
-
Galderma Acquires CollaGenex
-
Takeda Strengthens Foothold in US
-
UK Spin-off Acquired by Roche for Multi-Million Figure
-
GSK Enters into Sirtuin Field with Latest Acquisition
- Section: Research & Development
-
Regulus' microRNA Proves Attractive to GSK